Variant report
Variant | esv1846697 |
---|---|
Chromosome Location | chr5:29459652-29485091 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs685645 | chr5:29459652-29459653 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs57033137 | chr5:29459680-29459681 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs375933379 | chr5:29459694-29459695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs368625894 | chr5:29459697-29459698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs373857020 | chr5:29459698-29459699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs386403409 | chr5:29459700-29459701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs56983294 | chr5:29459701-29459702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs564766356 | chr5:29459734-29459735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs59992712 | chr5:29459768-29459769 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs551789717 | chr5:29459776-29459777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567025490 | chr5:29459838-29459839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs573997073 | chr5:29459863-29459864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185840852 | chr5:29459933-29459934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191055869 | chr5:29459965-29459966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182947731 | chr5:29460006-29460007 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs371844250 | chr5:29460039-29460040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs589854 | chr5:29460048-29460049 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs571562815 | chr5:29460049-29460050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs538882537 | chr5:29460085-29460086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs77750282 | chr5:29460130-29460131 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553805759 | chr5:29460168-29460169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572174180 | chr5:29460189-29460190 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs542389593 | chr5:29460191-29460192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544041017 | chr5:29460198-29460199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185769055 | chr5:29460210-29460211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs192331188 | chr5:29460213-29460214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs1665494 | chr5:29460222-29460223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183430541 | chr5:29460228-29460229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs139725690 | chr5:29460282-29460283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200019149 | chr5:29460359-29460360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs140790845 | chr5:29460368-29460369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs9292326 | chr5:29460382-29460383 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs187750345 | chr5:29460404-29460405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545646974 | chr5:29460407-29460408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs560607146 | chr5:29460417-29460418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146668688 | chr5:29460447-29460448 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs549596893 | chr5:29460494-29460495 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567900100 | chr5:29460503-29460504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548976502 | chr5:29460515-29460516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs531799119 | chr5:29460524-29460525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs72749369 | chr5:29460527-29460528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs36062225 | chr5:29460528-29460529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs571592169 | chr5:29460555-29460556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs61503356 | chr5:29460586-29460587 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs373250189 | chr5:29460795-29460796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs139046310 | chr5:29460797-29460798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs536180815 | chr5:29460804-29460805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550283272 | chr5:29460811-29460812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554300447 | chr5:29460836-29460837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs575833388 | chr5:29460868-29460869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 20409316 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 19553991 | CNVD |
Lung cancer | 19553991 | CNVD |
Melanoma | 19553991 | CNVD |
Ovarian cancer | 19553991 | CNVD |
Prostate cancer | 19553991 | CNVD |
Non-small cell lung cancer | 17156491 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:29456800-29461400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr5:29461200-29461600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr5:29461200-29461600 | Enhancers | Brain Inferior Temporal Lobe | brain |
4 | chr5:29461400-29461800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr5:29461600-29462800 | Weak transcription | Brain Inferior Temporal Lobe | brain |
6 | chr5:29461800-29467000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr5:29462400-29463000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
8 | chr5:29462800-29463000 | Enhancers | Brain Inferior Temporal Lobe | brain |
9 | chr5:29463000-29464000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
10 | chr5:29464000-29464200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
11 | chr5:29466200-29468200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr5:29471400-29471800 | Enhancers | Hela-S3 | cervix |
13 | chr5:29471400-29472000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
14 | chr5:29471600-29472000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr5:29471600-29472000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr5:29471600-29472000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr5:29475800-29476200 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |